Quantification of diffuse parenchymal lung disease in non‐small cell lung cancer patients with definitive concurrent chemoradiation therapy for predicting radiation pneumonitis
Abstract Background We sought to quantify diffuse parenchymal lung disease (DPLD) extent using quantitative computed tomography (CT) analysis and to investigate its association with radiation pneumonitis (RP) development in non‐small cell lung cancer (NSCLC) patients receiving definitive concurrent...
Main Authors: | Ye Chan An, Jong Hoon Kim, Jae Myung Noh, Kyung Mi Yang, You Jin Oh, Sung Goo Park, Hong Ryul Pyo, Ho Yun Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.15156 |
Similar Items
-
Etiologic Classification of Diffuse Parenchymal (Interstitial) Lung Diseases
by: Matthias Griese
Published: (2022-03-01) -
The Characteristic of Transbronchial Lung Cryobiopsy in the Pathological Diagnosis of Hypersensitivity Pneumonitis
by: Shuuhei Ohno, et al.
Published: (2023-05-01) -
Radiotherapy dose–volume parameters predict facial lymphedema after concurrent chemoradiation for nasopharyngeal carcinoma
by: Donghyun Kim, et al.
Published: (2021-09-01) -
The Role of Radiology in Progressive Fibrosing Interstitial Lung Disease
by: Ahmad Abu Qubo, et al.
Published: (2022-01-01) -
PEDIATRIC HYPERSENSITIVE PNEUMONITIS POSITIVE EXPERIENCE IN MANAGEMENT
by: N. S. LEV, et al.
Published: (2017-07-01)